
NanoTalks by Curapath is your gateway to the future of healthcare nanotechnology. In each episode, we explore the latest trends in lipid and polymer nanoparticles a groundbreaking field transforming how next-generation therapies and vaccines are developed. Discover how these tiny, multifunctional structures can enhance treatment effectiveness, minimize side effects, and open the door to innovations that once seemed out of reach. Join us as we delve into cutting-edge research, clinical insights, and the major advances shaping modern medicine
Hot topics
NanoTalks
- Miguel Ángel Esteve
- 19/05/2025
mRNA technologies: Vaccines VS Therapeutics
Explore how mRNA technologies are transforming both global health and precision medicine, and why flexible, GMP-ready manufacturing is key to success.
From high-volume vaccines to personalized therapeutics, this post explores the shared science behind mRNA platforms and the diverging manufacturing strategies they require. Learn how partnering with an experienced CDMO like Curapath can help bring your mRNA product from concept to clinic with confidence

Keep exploring Curapath Blog , there is more NanoTalks yet to explore
Recent Articles
- Miguel Ángel Esteve
- May 19, 2025
Messenger RNA (mRNA) technology surged into the global spotlight during the COVID-19 pandemic, showcasing its power to...
- Miguel Ángel Esteve
- April 29, 2025
Early-stage research frequently takes center stage in the fields of biopharmaceuticals and the development of advanced...
- Elena Gallon
- April 8, 2025
Sterile filtration and aseptic fill & finish are essential components in gene therapy manufacturing, critical for...
- Samuel García
- March 20, 2025
Nanoparticle-based drug delivery has revolutionized how therapeutics can be transported and released within the human...
- Miguel Ángel Esteve
- March 11, 2025
Process Performance Qualification (PPQ) is a critical part of the pharmaceutical manufacturing validation lifecycle,...
- Miguel Ángel Esteve
- March 4, 2025
Currently, lipid nanoparticles (LNPs) stand as the predominant delivery system for emerging mRNA-based therapeutic...
- Miguel Ángel Esteve
- February 10, 2025
As RNA-based therapeutics continue to revolutionize modern medicine, lipid nanoparticles (LNPs) have emerged as the...
- Miguel Ángel Esteve
- February 10, 2025
Peptides have emerged as promising therapeutic agents due to their high specificity and biocompatibility. However,...
Keep updated
Sign Up for NanoTalks
Subscribe to NanoTalks, the magazine of Curapath. Stay up to date on the latest developments, trends and news in the world of non-viral vectors, plus discover the latest advances in nanobiotechnology.